Urotensin receptors as a new target for CLP induced septic lung injury in mice

[1]  D. Hanidziar,et al.  More of the Gut in the Lung: How Two Microbiomes Meet in ARDS , 2018, The Yale journal of biology and medicine.

[2]  I. Cinar,et al.  The role of urotensin‐II and its receptors in sepsis‐induced lung injury under diabetic conditions , 2018, European journal of pharmacology.

[3]  C. A. Prauchner.  Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy. , 2017, Burns : journal of the International Society for Burn Injuries.

[4]  Zekai Halici,et al.  Sepsis and Septic Shock: Current Treatment Strategies and New Approaches. , 2017, The Eurasian journal of medicine.

[5]  G. Cao,et al.  UII/GPR14 is involved in NF-κB-mediated colonic inflammation in vivo and in vitro. , 2016, Oncology reports.

[6]  Y. Bayir,et al.  Blocking of urotensin receptors as new target for treatment of carrageenan induced inflammation in rats , 2016, Peptides.

[7]  C. Bhan,et al.  Role of cellular events in the pathophysiology of sepsis , 2016, Inflammation Research.

[8]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[9]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[10]  Lijing Sun,et al.  Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits , 2015, BioMed research international.

[11]  M. Goldim,et al.  Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis , 2015, Inflammation.

[12]  L. Liu,et al.  The UII/UT System Mediates Upregulation of Proinflammatory Cytokines through p38 MAPK and NF-κB Pathways in LPS-Stimulated Kupffer Cells , 2015, PloS one.

[13]  Liang Zhao,et al.  Effects of urotensin-II on cytokines in early acute liver failure in mice. , 2015, World journal of gastroenterology.

[14]  S. Opal,et al.  Endothelial barrier dysfunction in septic shock , 2015, Journal of internal medicine.

[15]  A. Stromberg,et al.  Increased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis. , 2015, American journal of physiology. Heart and circulatory physiology.

[16]  Xi-Long Zheng,et al.  Urotensin II increases foam cell formation by repressing ABCA1 expression through the ERK/NF-κB pathway in THP-1 macrophages. , 2014, Biochemical and biophysical research communications.

[17]  E. Akpinar,et al.  What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  Liang Zhao,et al.  Inhibition of UII/UTR System Relieves Acute Inflammation of Liver through Preventing Activation of NF-κB Pathway in ALF Mice , 2013, PloS one.

[19]  S. Atamanalp,et al.  Peripheral 5-HT7 receptors as a new target for prevention of lung injury and mortality in septic rats. , 2013, Immunobiology.

[20]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[21]  B. Lee,et al.  Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells , 2013, Biomolecules & therapeutics.

[22]  S. Atamanalp,et al.  Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis. , 2013, International immunopharmacology.

[23]  Y. Bayir,et al.  The protective effect of amiodarone in lung tissue of cecal ligation and puncture-induced septic rats: a perspective from inflammatory cytokine release and oxidative stress , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[24]  D. Behm,et al.  Genetic and Pharmacological Manipulation of Urotensin II Ameliorate the Metabolic and Atherosclerosis Sequalae in Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Karin,et al.  NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.

[26]  M. H. Uyanik,et al.  Effects of diabetes on cytokines and oxidative organ injury in a rat model of sepsis. , 2012, Cellular and molecular biology.

[27]  F. Atalay,et al.  Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study , 2011, Clinical and experimental immunology.

[28]  A. Oral,et al.  The Effects of Montelukast on Antioxidant Enzymes and Proinflammatory Cytokines on the Heart, Liver, Lungs, and Kidneys in a Rat Model of Cecal Ligation and Puncture–Induced Sepsis , 2011, TheScientificWorldJournal.

[29]  C. Libert,et al.  Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? , 2011, Trends in microbiology.

[30]  W. Aird,et al.  Influence of diabetes on endothelial cell response during sepsis , 2011, Diabetologia.

[31]  Jérôme Leprince,et al.  Urotensin II, from fish to human , 2010, Annals of the New York Academy of Sciences.

[32]  A. Giaid,et al.  Role of urotensin II in health and disease. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  B. Z. Altunkaynak,et al.  &agr;-LIPOIC ACID AS A POTENTIAL TARGET FOR THE TREATMENT OF LUNG INJURY CAUSED BY CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS MODEL IN RATS , 2009, Shock.

[34]  J. Dingemanse,et al.  Pharmacokinetics and Pharmacodynamics of the Urotensin‐II Receptor Antagonist Palosuran in Healthy Male Subjects , 2009, Journal of clinical pharmacology.

[35]  A. Miyazaki,et al.  Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases. , 2009, Current medicinal chemistry.

[36]  B. Cheung,et al.  The role of urotensin II in the metabolic syndrome , 2008, Peptides.

[37]  P. Pacaud,et al.  Urotensin II is a New Chemotactic Factor for UT Receptor-Expressing Monocytes1 , 2007, The Journal of Immunology.

[38]  D. Annane,et al.  Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS , 2006 .

[39]  M. Aurrand-Lions,et al.  Angiogenesis and inflammation face off , 2006, Nature Medicine.

[40]  F. Cunha,et al.  A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Cheung,et al.  Urotensin II: Its Function in Health and Its Role in Disease , 2005, Cardiovascular Drugs and Therapy.

[42]  N. Aiyar,et al.  Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[43]  R. Hannan,et al.  Urotensin II: the old kid in town , 2004, Trends in Endocrinology & Metabolism.

[44]  A. Unlu,et al.  The Protective Effect of N-Acetylcysteine on Apoptotic Lung Injury in Cecal Ligation and Puncture-Induced Sepsis Model , 2003, Shock.

[45]  C. Krettek,et al.  Polymicrobial sepsis induces organ changes due to granulocyte adhesion in a murine two hit model of trauma. , 2002, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[46]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[47]  A. Davenport,et al.  Urotensin II: fish neuropeptide catches orphan receptor. , 2000, Trends in pharmacological sciences.

[48]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.

[49]  Y. Naito,et al.  Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. , 1998, Digestive diseases and sciences.

[50]  M. Jordana,et al.  Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. , 1994, Journal of immunology.

[51]  Y. Sun,et al.  A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.

[52]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[53]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[54]  G. Cao,et al.  UII / GPR 14 is involved in NF-κ B-mediated colonic inflammation in vivo and in vitro , 2022 .